Indian Pharma stocks have opened the day on a mixed note with Dishman Pharma Ltd and JB Chemicals Ltd leading the gains. However, Natco Pharma Ltd and Glenmark Pharma Ltd were facing maximum selling pressure. As per a leading financial daily, the domestic Pharma sector is likely to be offered a financing scheme by the Modi government for the upgradation of manufacturing facilities and meet stringent standards of the world's leading export markets. It is important to note here that Indian pharma companies are facing a tough time on account of quality issues raised by US Food and Drug Administation (USFDA). One of the options being considered is an interest subsidy scheme for the upgradation of manufacturing facilities. Besides, the Government is also aims to boost the active ingredients segment of the domestic industry, which has suffered from cheap Chinese imports.